Sumitomo Chemical India Ltd (SUMICHEM) — concall transcript | 30 June 2026

Sumitomo Chemical India held its 26th AGM on July 27, 2026, reviewing FY2025-26 results and announcing leadership succession. Chairman Dr. Mukul Asher highlighted record profitability with PAT at ₹543 crore, 42% gross margin, and 31% ROCE, driven by branded formulations (81% of domestic sales) and specialty chemicals (30%). Capex expansion at Dahej ([amount context mismatch] crore project) progresses toward commercialization. Management expressed cautious optimism for FY2026-27 amid delayed monsoon and El Niño risks, citing full capacity and strong balance sheet (₹2,113 crore cash). Key transitions include Dr. Suresh Ramachandran's proposed appointment as Managing Director from September 1, 2026, and Chetan Shah's shift to Non-Executive Director. Dividend of ₹1.30 per share was proposed. Shareholders raised concerns about capacity utilization, Chinese competition, royalty payments, and export tariffs.